HeartBeam to Present at LD Micro Invitational XII Conference on June 7, 2022
May 25 2022 - 8:31AM
Business Wire
HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage
digital healthcare company with a proprietary ECG telemedicine
technology for heart attack detection, will present at the
in-person LD Micro Invitational XII Conference being held at the
Four Seasons in Westlake Village, CA on June 7 – 9, 2022.
HeartBeam Chief Financial Officer Rick Brounstein, and Chief
Business Officer Jon Hunt, PhD, will conduct 25-minute in-person
one-on-one meetings and deliver the Company’s in-person
presentation which can be viewed live and via replay at the webcast
link below and will also be available on the HeartBeam investor
relations website at ir.heartbeam.com.
LD Micro Invitational XII Date: June 7 – 9, 2022
Location: Westlake Village, CA Presentation Time: June 7, 2022 at
4:00 pm ET (1:00 pm PT) in TRACK 4 Webcast:
https://ldinv12.mysequire.com/ Format: In-person 1x1’s and
Presentations Speakers: Chief Financial Officer Rick Brounstein,
Chief Business Officer Jon Hunt, PhD Conference Website: Click
here
For more information on the LD Micro Invitational XII Conference
or to schedule a one-on-one meeting with HeartBeam management,
please contact your conference representative or you may also email
your request to BEAT@mzgroup.us or call Chris Tyson at (949)
491-8235.
About HeartBeam, Inc.
HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital
healthcare company with proprietary ECG telemedicine technology
that will redefine the way high risk cardiovascular patients are
diagnosed in an ambulatory setting at any time and any place. Its
breakthrough solution employs a reusable, credit card sized, 3D
vector ECG recording device and cloud-based software capable of
assisting a physician in diagnosing a wide range of cardiovascular
disease. HeartBeam is initially focusing on a huge unmet need of
helping diagnose heart attacks in patients outside of a medical
institution. No single lead ECG technology can offer this value to
patients and their physicians. This underserved market is several
times larger than the cardiac arrhythmia detection market based on
the prevalence of patients with coronary artery disease at high
risk of heart attack. For more information, visit
www.heartbeam.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220525005225/en/
Media and Investor Relations Contact: Chris Tyson
Executive Vice President MZ North America Direct: 949-491-8235
BEAT@mzgroup.us www.mzgroup.us
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Aug 2024 to Sep 2024
HeartBeam (NASDAQ:BEAT)
Historical Stock Chart
From Sep 2023 to Sep 2024